SCHEMBL19112345

SCHEMBL19112345

CC(C)N(Cc1ccc(-c2ccccn2)cc1)c1nc(NCCCO)nc2c1ncn2C(C)C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 15/20 0.57
▸ CCNA2 P20248 10/20 0.57
▸ CCNA1 P78396 9/20 0.57
▸ CDK9 P50750 8/20 0.57
▸ DYRK1A Q13627 8/20 0.57
▸ CDK5 Q00535 8/20 0.57
▸ CCNT1 O60563 7/20 0.57
▸ CDK5R1 Q15078 7/20 0.57
▸ CSNK1A1 P48729 5/20 0.57
▸ GSK3A P49840 1/20 0.55
▸ GSK3B P49841 1/20 0.55
▸ CDK1 P06493 8/20 0.54
▸ CCNB1 P14635 6/20 0.54
▸ CCNB2 O95067 4/20 0.54
▸ CCNB3 Q8WWL7 4/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54
▸ CCNE1 P24864 5/20 0.52
▸ CCNK O75909 2/20 0.52
▸ CDK12 Q9NYV4 2/20 0.52
▸ CDK4 P11802 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19112174 0.91 CDK2 (0.58) CDK2CCNA2CCNA1CDK9DYRK1A
SCHEMBL19112253 0.88 CDK2 (0.71) CDK2CCNA2CCNA1CDK9DYRK1A
SCHEMBL29326802 0.81 CDK2 (0.56) CDK2CCNA2CCNA1CDK9DYRK1A
SCHEMBL15940645 0.81 CDK2 (0.79) CDK2CCNA2CCNA1CDK9DYRK1A
SCHEMBL3389347 0.79 CDK1 (0.68) CDK2CCNA2CCNA1DYRK1ACDK5
SCHEMBL19112166 0.79 CDK2 (0.72) CDK2CCNA2CCNA1CDK9DYRK1A
SCHEMBL7889584 0.78 CDK2 (0.82) CDK2CCNA2CCNA1CDK9DYRK1A
SCHEMBL19112176 0.77 CDK2 (0.61) CDK2CCNA2CCNA1CDK9DYRK1A
SCHEMBL19112097 0.75 CDK2 (0.75) CDK2CCNA2CCNA1CDK9DYRK1A
SCHEMBL19111955 0.75 CDK2 (0.75) CDK2CCNA2CCNA1CDK9DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2664619-B1 Purine derivatives as tools for screening anti-Alzheimer compounds MANROS THERAPEUTICS (FR) 2017-07-12 — — EP disclosed
Send feedback